Vault-13

GENERAL ATLANTIC, L.P.

New York, NY · CIK 1017645 · 13F filing filed 2025-08-14

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$3.6bn reported value +21.8% vs Q1 2025
15positions
97.4%in top 10
3 new 1 added 2 reduced 3 sold out vs Q1 2025

Holdings, Q2 2025

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 DLOCAL LTD CLASS A COM DLO DLO 63,906,695 $724.7m19.97% 19.97% UnchangedShares held: Q3 2024 63.9m, Q4 2024 63.9m, Q1 2025 63.9m, Q2 2025 63.9m
2 CHIME FINL INC COM SHS CL A CHYM CHYM 19,208,760 $662.9m18.26% 18.26% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 19.2m
3 ALIGNMENT HEALTHCARE INC COM ALHC ALHC 43,993,323 $615.9m16.97% 16.97% ReducedShares held: Q3 2024 61.0m, Q4 2024 61.0m, Q1 2025 61.0m, Q2 2025 44.0m -17.0m -17,000,000 -27.9%
4 XP INC CL A XP XP 25,517,733 $515.5m14.20% 14.20% ReducedShares held: Q3 2024 29.6m, Q4 2024 29.6m, Q1 2025 29.6m, Q2 2025 25.5m -4.1m -4,100,000 -13.8%
5 AKERO THERAPEUTICS INC COM AKRO AKRO 5,733,989 $306.0m8.43% 8.43% AddedShares held: Q3 2024 5.2m, Q4 2024 5.2m, Q1 2025 5.2m, Q2 2025 5.7m +500.0k +500,000 9.6%
6 ALKAMI TECHNOLOGY INC COM ALKT ALKT 9,645,318 $290.7m8.01% 8.01% UnchangedShares held: Q3 2024 15.5m, Q4 2024 9.6m, Q1 2025 9.6m, Q2 2025 9.6m
7 PHARVARIS N V COM PHVS PHVS 7,531,252 $132.6m3.65% 3.65% UnchangedShares held: Q3 2024 7.5m, Q4 2024 7.5m, Q1 2025 7.5m, Q2 2025 7.5m
8 CENTESSA PHARMACEUTICALS PLC SPONSORED ADS SPONSORED ADS 9,681,818 $127.2m3.51% 3.51% UnchangedShares held: Q3 2024 9.7m, Q4 2024 9.7m, Q1 2025 9.7m, Q2 2025 9.7m
9 WEBULL CORP ORD SHS BULL BULL 7,148,051 $85.5m2.36% 2.36% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 7.1m
10 EUROPEAN WAX CTR INC CLASS A COM EWCZ EWCZ 13,110,492 $73.8m2.03% 2.03% UnchangedShares held: Q3 2024 13.1m, Q4 2024 13.1m, Q1 2025 13.1m, Q2 2025 13.1m
11 ROYALTY PHARMA PLC SHS CLASS A RPRX RPRX 1,500,000 $54.0m1.49% 1.49% UnchangedShares held: Q3 2024 1.5m, Q4 2024 1.5m, Q1 2025 1.5m, Q2 2025 1.5m
12 RISKIFIED LTD SHS CL A RSKD RSKD 5,324,998 $26.6m0.73% 0.73% UnchangedShares held: Q3 2024 5.3m, Q4 2024 5.3m, Q1 2025 5.3m, Q2 2025 5.3m
13 ADAGENE INC ADS ADAG ADAG 3,825,952 $7.5m0.21% 0.21% UnchangedShares held: Q3 2024 264.0k, Q4 2024 3.8m, Q1 2025 3.8m, Q2 2025 3.8m
14 ALUMIS INC COM ALMS ALMS 1,297,530 $3.9m0.11% 0.11% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 1.3m
15 GROVE COLLABORATIVE HOLD INC COM CL A GROV GROV 2,474,859 $2.8m0.08% 0.08% UnchangedShares held: Q3 2024 936.0k, Q4 2024 2.5m, Q1 2025 2.5m, Q2 2025 2.5m

Sold out since Q1 2025

SecurityTickerShares held beforeValue then
IMMUNOCORE HLDGS PLC IMCR IMCR 1,261,684 $37.4m1.3m shares
ACELYRIN INC 2,695,327 $6.7m2.7m shares
CONTEXTLOGIC INC LOGC LOGC 609,616 $4.3m609.6k shares

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
DLOCAL LTD DLO · 13D · filed 2026-08-19 DLO 21.4%≈ $478.4m -6.9 pts 13D 2026-08-19
ALKAMI TECHNOLOGY INC ALKT · 13D · filed 2026-05-15 ALKT 18.1%≈ $351.9m +1.8 pts 13D 2026-05-15
LIFTOFF MOBILE INC LFTO · 13D · filed 2026-06-12 LFTO 15.0%≈ $608.1m new 13D 2026-06-12
SEAPORT THERAPEUTICS INC SPTX · 13D · filed 2026-05-11 SPTX 11.5%≈ $132.5m new 13D 2026-05-11
AKERO THERAPEUTICS INC AKRO · 13G · filed 2025-05-15 AKRO 8.4% 13G 2025-05-15
PHARVARIS N V PHVS · 13G · filed 2026-08-14 PHVS 7.6%≈ $185.3m 13G 2026-08-14
CHIME FINL INC CHYM · 13G · filed 2025-11-10 CHYM 5.6%≈ $393.4m new 13G 2025-11-10
XP INC XP · 13D · filed 2025-12-04 XP 5.4%≈ $370.1m 13D 2025-12-04

Trades reported as a company insider in Q2 2025

Owning 10% or more of a company, or having someone on its board, makes this manager an insider there: it reports its trades in that company's shares on Form 4 within two business days. Open-market and private purchases and sales only.

DateCompanyTickerTradeShares ValueTheir holding
2025-05-19 ALIGNMENT HEALTHCARE INC Director · See footnote ALHC Sold 17,000,000 $259.8m17.0m shares -28%